Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Share-based Compensation (2018 - 2025)

Historic Share-based Compensation for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $3.4 million.

  • Neurogene's Share-based Compensation rose 3601.46% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 11506.14%. This contributed to the annual value of $8.3 million for FY2024, which is 48674.19% up from last year.
  • According to the latest figures from Q3 2025, Neurogene's Share-based Compensation is $3.4 million, which was up 3601.46% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Share-based Compensation peaked at $4.0 million during Q1 2025, and registered a low of $293000.0 during Q1 2023.
  • In the last 3 years, Neurogene's Share-based Compensation had a median value of $2.5 million in 2024 and averaged $2.2 million.
  • Per our database at Business Quant, Neurogene's Share-based Compensation soared by 60056.34% in 2024 and then skyrocketed by 3601.46% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Share-based Compensation stood at $355000.0 in 2023, then skyrocketed by 600.56% to $2.5 million in 2024, then soared by 35.3% to $3.4 million in 2025.
  • Its Share-based Compensation stands at $3.4 million for Q3 2025, versus $3.4 million for Q2 2025 and $4.0 million for Q1 2025.